🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine how prior therapy with alendronate or risedronate in postmenop...
Status
Completed
Location
sanofi-aventis, US
Start Date
2004-03
Trial ID
NCT00130403
Treatments Being Tested
The study hypothesis is that nutritional supplementation together with bisp...
Status
Completed
Location
Department of Geriatric Medicine R94, Karolinska University Hospital
Start Date
2004-12
Trial ID
NCT01950169
Treatments Being Tested
RATIONALE: Bisphosphonates, such as risedronate, may help improve bone heal...
Status
Withdrawn
Location
Inselspital Bern
Start Date
2003-02
Trial ID
NCT00324714
Treatments Being Tested
in recent years the search for therapeutic protocols that could enhance the...
Status
Completed
Location
Multiple Locations
Start Date
2015-01-01
Trial ID
NCT05803681
Treatments Being Tested
Primary Objective: * To demonstrate that risedronate 35-mg once weekly is ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2002-09
Trial ID
NCT00402441
Treatments Being Tested
Osteoporotic fracture is a common public-health problem in the whole world....
Status
Completed
Location
Department of Family Medicine, National Cheng Kung Univ Hosp
Start Date
2020-11-01
Trial ID
NCT05366621
Treatments Being Tested
Patients who have received the appropriate number of years of alendronate o...
Status
Completed
Location
Warner Chilcott Research Facility
Start Date
2004-01
Trial ID
NCT00778154
RATIONALE: Learning about the effect of exemestane and anastrozole on bone ...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2006-04-24
Trial ID
NCT00354302
Osteogenesis Imperfecta-related hearing loss usually occurs in individuals ...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-11-02
Trial ID
NCT04152551
Treatments Being Tested
Two year study to determine the safety and efficacy of weekly 35 mg Risedro...
Status
Completed
Location
Research Site
Start Date
2002-06
Trial ID
NCT00619957
Treatments Being Tested